Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of an Artificial Intelligence-Driven Novel Response Evaluation Framework and Its Biological Characterization

NCT07685548 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07685548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07685548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of an Artificial Intelligence-Driven Novel Response Evaluation Framework and Its Biological Characterization
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
June 30, 2029
Enrollment
6,120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, neoplasms, solid tumor cancer